Charles D. Lopez

Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival

Charles E. Gast, Alain D. Silk, Luai Zarour et al. · Science Advances · 2018 · 338 citations · Full text

Medicine, Cell Biology, Oncology +13

APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant <i>nab</i>-paclitaxel plus gemcitabine (<i>nab</i>-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma.

Margaret A. Tempero, Michele Reni, Hanno Riess et al. · Journal of Clinical Oncology · 2019 · 143 citations

Medicine, Oncology, Surgery +16

Unusual Topogenic Sequence Directs Prion Protein Biogenesis

Charles D. Lopez, C. Spencer Yost, Stanley B. Prusiner et al. · Science · 1990 · 133 citations

Life Sciences, Biochemistry, Molecular Biology +13

Adjuvant <i>nab</i> -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Margaret A. Tempero, Uwe Pelzer, Eileen M. O’Reilly et al. · Journal of Clinical Oncology · 2022 · 132 citations · Full text

Medicine, Oncology, Pharmacology +13

Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein

C. Spencer Yost, Charles D. Lopez, Stanley B. Prusiner et al. · Nature · 1990 · 130 citations

Life Sciences, Biochemistry, Molecular Biology +13